Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;36(1):50-58.
doi: 10.2337/cd17-0053.

Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys

Robert Engler  1   2 , Timothy L Routh  2 , Joseph Y Lucisano  2
Affiliations

Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys

Robert Engler et al. Clin Diabetes. 2018 Jan.

Abstract

IN BRIEF A patient-centered approach to device design can provide important advantages in optimizing diabetes care technology for broadened adoption and improved adherence. Results from two surveys of people with diabetes and the parents of children with diabetes (n = 1,348) regarding continuous glucose monitoring (CGM) devices reveal the importance of the concept of "user burden" in patients' and caregivers' evaluations of the acceptability of available devices. Survey respondents' strongly favorable reactions to a proposed 1-year, fully implanted CGM device with no skin-attached components further confirm that minimizing system obtrusiveness will likely be of significant value in reducing hurdles to CGM device use and adherence.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Frequency of CGM calibration reported in Survey 2 for adults and children currently using CGM. Among adult participants, average calibration frequency for insulin pump users (2.54 times/day) was not different from the frequency reported by those using an MDI regimen (2.27 times/day).
FIGURE 2.
FIGURE 2.
Frequency of SMBG before treatment with carbohydrates or insulin reported in Survey 2. Participants were asked what percentage of time in quartiles they use SMBG to confirm a result before treating (solid bars). About half reported checking SMBG before treatment at least half of the time (hatched bar).
FIGURE 3.
FIGURE 3.
Frequency of reported problems among adult current and past CGM users in Survey 2.
FIGURE 4.
FIGURE 4.
Frequency of reported problems among parents of children who were current or past CGM users in Survey 2.
FIGURE 5.
FIGURE 5.
Photograph of the self-contained, implanted CGM model shown to participants in Surveys 1 and 2.
FIGURE 6.
FIGURE 6.
Likelihood of adoption of the described fully implanted CGM device among adult participants in Survey 1.
See this image and copyright information in PMC

References

    1. DCCT Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986 - PubMed
    1. Nathan DM; DCCT/EDIC Research Group . The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview. Diabetes Care 2014;37:9–16 - PMC - PubMed
    1. DCCT/EDIC Study Research Group Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC study 30-year follow-up. Diabetes Care 2016;39:686–693 - PMC - PubMed
    1. JDRF Continuous Glucose Monitoring Study Group Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464–1476 - PubMed
    1. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34:795–800 - PMC - PubMed